Status:
COMPLETED
OLE Study to Evaluate Safety / Efficacy of ZD4522
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolaemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the long term safety of Crestor.
Eligibility Criteria
Inclusion
- Completion of previous Crestor study as listed in the protocol.
Exclusion
- Pregnant or breast feeding women, or not using appropriate contraception.
- Abnormal lab values as listed in the protocol.
Key Trial Info
Start Date :
August 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2005
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT00654303
Start Date
August 1 1999
End Date
February 1 2005
Last Update
March 16 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.